Successful Surgical Treatment of Mitral Valve Endocarditis Caused by Brucella: A Case Report
DOI:
https://doi.org/10.59958/hsf.5857Keywords:
brucellosis endocarditis, mitral valve vegetation, early diagnosis, surgical treatment, anti-infectionAbstract
Brucellosis endocarditis is a rare but life-threatening complication of brucellosis, involving congenital, prosthetic and even native valves. Its diagnosis and treatment is a great challenge for doctors. The patient's prognosis requires prompt diagnosis and continuous evaluation of treatment plans to assess the need for either surgical intervention of the infected valves or continuation of antibiotic therapy alone. We present a patient with brucellosis endocarditis, predominantly involving the mitral valve, presenting with vegetations and prolapse of the anterior leaflet of the mitral valve with moderate to severe regurgitation. The patient was treated with triple antibiotic therapy before surgery. After the patient's blood culture results were negative, we removed the infected mitral valve vegetations and performed a mitral valve replacement. The patient was successfully extubated 4 hours after surgery and discharged 11 days after surgery. After discharge, the patient continued to receive triple antibiotic therapy for 2 months and was followed up at the cardiac surgery and infectious disease outpatient clinics.
References
Madkour MM. Madkour’s brucellosis. 2nd edn. Springer: New York, NY. 2001.
Ugarriza LF, Porras LF, Lorenzana LM, Rodríguez-Sánchez JA, García-Yagüe LM, Cabezudo JM. Brucellar spinal epidural abscesses. Analysis of eleven cases. British Journal of Neurosurgery. 2005; 19: 235–240.
Li X, Wang T, Wang Y, Xie S, Tan W, Li P. Short- and long-term follow-up outcomes of patients with Brucella endocarditis: a systematic review of 207 Brucella endocarditis Cases. Bioengineered. 2021; 12: 5162–5172.
Willems SA, Brouwers JJWM, Eefting D. Aortic and Iliac Involvement in Brucellosis - A Rare but Life Threatening Manifestation: A Review of the Literature. European Journal of Vascular and Endovascular Surgery. 2022; 63: 743–750.
Reguera JM, Alarcón A, Miralles F, Pachón J, Juárez C, Colmenero JD. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. European Journal of Clinical Microbiology & Infectious Diseases. 2003; 22: 647–650.
Cay S, Cagirci G, Maden O, Balbay Y, Aydogdu S. Brucella endocarditis - a registry study. Kardiologia Polska. 2009; 67: 274–280.
Lee SA, Kim KH, Shin HS, Lee HS, Choi HM, Kim HK. Successful Medical Treatment of Prosthetic Mitral Valve Endocarditis Caused by Brucella abortus. Korean Circulation Journal. 2014; 44: 441–443.
Sasmazel A, Baysal A, Fedakar A, Buğra O, Ozkokeli M, Büyükbayrak F, et al. Treatment of Brucella endocarditis: 15 years of clinical and surgical experience. The Annals of Thoracic Surgery. 2010; 89: 1432–1436.
Cohen N, Golik A, Alon I, Zaidenstein R, Dishi V, Karpuch J, et al. Conservative treatment for Brucella endocarditis. Clinical Cardiology. 1997; 20: 291–294.
Herrick JA, Lederman RJ, Sullivan B, Powers JH, Palmore TN. Brucella arteritis: clinical manifestations, treatment, and prognosis. The Lancet. Infectious Diseases. 2014; 14: 520–526.
Sanchez-Gonzalez J, Garcia-Delange T, Martos F, Colmenero JD. Thrombosis of the abdominal aorta secondary to Brucella spondylitis. Infection. 1996; 24: 261–262.
Lu D, Zhou YJ, Jing ZC. Epidemiology of Brucellosis and why should we strengthen the awareness of brucella endocarditis: clinical features, diagnosis, treatment and outcome. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48: 901–905. (In Chinese)
Keshtkar-Jahromi M, Razavi SM, Gholamin S, Keshtkar-Jahromi M, Hossain M, Sajadi MM. Medical versus medical and surgical treatment for brucella endocarditis. The Annals of Thoracic Surgery. 2012; 94: 2141–2146.
Mert A, Kocak F, Ozaras R, Tabak F, Bilir M, Kucukuglu S, et al. The role of antibiotic treatment alone for the management of Brucella endocarditis in adults: a case report and literature review. Annals of Thoracic and Cardiovascular Surgery. 2002; 8: 381–385.
